Projects

FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III - Spain 

Project overview (since 2010-01-01):

Start dateProjectacronymrolefundingpartners
2019-10-01The life cycle of extracellular vesicles in prostate cancer: from biogenesis and homing, to functional relevance proEVLifeCycleparticipant2.672.56210
2019-09-01Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine TranSYSparticipant3.937.79913
2019-05-01BRInGing nano-pHoTonics into the brain NanoBRIGHTparticipant3.496.1984
2019-01-01European Proteomics Infrastructure Consortium providing Access EPIC-XSparticipant9.986.18618
2018-10-01METLINK: Identification of links between cancer cell growth and metabolism genes. METLINKcoordinator158.1222
2018-06-01Chronic Systemic Inflammation: Functional organ cross-talk in inflammatory disease and cancer CSI-Funparticipant2.499.8752
2017-04-01Long range-acting drivers of premetastatic niches in melanoma METMELcoordinator170.1221
2016-04-01Nanomedicine upscaling for early clinical phases of multimodal cancer therapy NoCanTherparticipant7.113.77912
2016-01-01The Physiology of Nutrient Sensing by mTOR NutrientSensingVivoparticipant1.846.4941
2015-12-01Training Network for the Immunotherapy of Cancer IMMUTRAINparticipant3.627.52510
2015-11-01Global dynamics of topoisomerase-induced DNA breaks TOPOmicscoordinator2.000.0002
2015-10-01Integrating Genomics and Avatar Mouse Models to Personalize Pancreatic Cancer Treatment AVATARparticipant2.498.6882
2015-10-01New Frontiers in Cellular Reprogramming: Exploiting Cellular Plasticity CELLPLASTICITYcoordinator2.488.8501
2015-09-01ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences. ELIXIR-EXCELERATEparticipant19.051.48248
2015-09-01Breast Cancer Risk after Diagnostic Gene Sequencing (BRIDGES) BRIDGESparticipant6.200.00018
2015-06-01Open Mining INfrastructure for TExt and Data OpenMinTeDparticipant5.375.53616
2014-07-01DNA Damage Response (DDR) signaling in tumor formation and therapeutic resistance of gliomas GLIDDcoordinator100.0001
2014-03-01Investigating the causes and consequences of replication stress in mammalian health RSHEALTHparticipant1.997.8191
2013-11-01Integrative Analysis of Gene Functions in Cellular and Animal Models of Pancreatic Cancer CAM-PACparticipant11.193.10814
2013-09-01Translation of novel Biomarkers for Bladder Cancer for clinical outcome prediction TRANSBIOBCparticipant3.260.3594
2013-07-01Bioinformatics and Integrative Genomics for a Novel Personalized Cancer Therapy PERSMEDOMICScoordinator100.0001
2013-03-01Improving the selectivity of kinase inhibitors: Characterizing binding mechanisms of inhibitors targeting inactive states and allosteric sites KIBINDINGparticipant168.8962
2012-11-01"Risk, Stem Cells and Tissue Kinetics – Ionising Radiation" RISK - IRparticipant6.685.00012
2012-11-01"RD-CONNECT: An integrated platform connecting registries, biobanks and clinical bioinformatics for rare disease research" RD-CONNECTparticipant11.997.11127
2012-10-01Joint training and research network on Chromatin Dynamics and the DNA Damage Response ADDRESSparticipant3.804.29410
2012-09-01Role of the protein kinase Mastl in Cell Division and Cancer Mastl CDCcoordinator226.5481
2011-10-01A BLUEPRINT of Haematopoietic Epigenomes BLUEPRINTparticipant29.996.66445
2011-10-01Clonal analysis in pancreatic development, differentiation and carcinogenesis PanCloncoordinator230.9801
2011-07-01Rational designing of new meganucleases as molecular scissors for genomic tailoring SMARTBREAKERcoordinator75.0001
2011-06-13Multifunctional Nanotechnology for selective detection and Treatment of cancer MULTIFUNparticipant9.799.99417
2011-04-01Development of novel diagnostic and therapeutic approaches to improve patient outcome in lung and pancreatic tumours CANCERALIAcoordinator2.996.8097
2011-04-01Safer gene repair and targeting based on the monomeric meganuclease I-DmoI by design of homologous-recombination-inducing nickase activity DmoNickaseDesigncoordinator155.4171
2011-02-01Targeting the tumour microenvironment to improve pancreatic cancer prognosis EPC-TM-Netparticipant3.000.00017
2011-01-01A European Platform for Translational Cancer Research EUROCANPLATFORMparticipant11.998.45428
2011-01-01New approaches for the targeted therapy of Non-Small Cell Lung Cancer LUNGTARGETparticipant2.997.33210
2011-01-01Identifying biomarkers of ageing using whole transcriptomic sequencing EuroBATSparticipant2.998.6505
2011-01-01European Network for the Study of Adrenal Tumours - Structuring clinical research on adrenal cancers in adults ENS@T-CANCERparticipant5.993.97816
2010-11-01ASSET: Analysing and Striking the Sensitivities of Embryonal Tumours ASSETparticipant11.999.15619
2010-06-01Systems Biology of Mitosis MitoSysparticipant10.198.24114
2010-04-01Ras Genes in Health and Disease RAS AHEADparticipant2.496.1921
2010-03-01The role of activation-induced cytidine deaminase in inflammation-induced carcinogenesis InflAIDCancoordinator161.9001